Skip to main content

Accendra Health, Inc.

corporate_fare Company Profile

Accendra Health, Inc.

ACH·NYSE·Trade & Services·CIK 0000075252

General Accendra Health, Inc. is a nationwide provider of products, technology, and services that supports health beyond the hospital. The company connects patients, providers, and insurers, delivering solutions to promote better health outcomes and improve quality of life for people with chronic, complex, and acute health conditions. Its trusted brands, Apria and Byram Healthcare, have nearly 90 years of combined experience. The company is headquartered in Richmond, Virginia. On October 7, 2025, the company entered into an Equity Purchase Agreement to sell its Products & Healthcare Services (P&HS) business for an aggregate of $375 million in cash, subject to certain adjustments. This sale was completed on December 31, 2025. The company has retained a 5% equity interest in the P&HS business. General Accendra Health provides delivery of products, including disposable medical supplies sold directly to patients and home health agencies. It is a leading provider of integrated home healthcare equipment and related services in the U.S. The company offers a comprehensive range of products and services for in-home care and delivery across diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure (CPAP) and bi-level positive airway pressure devices, and patient support services).

Accendra Health, Inc. (NYSE:ACH) is a publicly traded company in the Trade & Services sector. Wiseek monitors ACH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Accendra Health Finalizes $1.5 Billion Debt Exchange and New Note Issuance
  • Accendra Health Finalizes $300M Revolver, Prices New First- and Second-Lien Notes
  • Accendra Health Finalizes Major Debt Exchange, Secures $539M First Lien Notes & $300M Revolver
  • Accendra Health Launches Debt Exchange and $326M New Money Offering
  • Accendra Health Details $1.5B Debt Optimization, Reports Q1 Loss Amid Revenue Decline

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.76B
Net Income
-$1.1B
Diluted EPS
-$14.31
Gross Profit
$1.29B
Operating Income
$27.46M
Cash & Equivalents
$281.99M
Total Debt
$250M
Debt / Equity
-0.54×
Net Margin
-39.8%
Shares Outstanding
76.39M sh
Source: 10-K · filed 2026-02-20 · accession 0001104659-26-018169

Dilution Risk

Low risk

Filing-implied dilution signals for ACH, detected from its recent SEC filings · based on capital-structure filings through 2026-07-15.

1 shelf registration

Shelf Registration Filed · No Immediate Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with A →
$3.19 -0.06% today
52-week range · as of 2026-06-25 $1.84 – $9.55
Market cap
$248.9M
Volume
262.1K (0.4× avg)
3-mo avg 626.6K
Live data · 2026-07-29 06:33 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed ACH - Latest Insights

ACH
Jun 25, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.17
Real-time Price: $3.19 info
Change: +$0.020 (+0.63%) info
Market Cap: $248.897M info
ACH
Jun 15, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $3.03
Real-time Price: $3.19 info
Change: +$0.160 (+5%) info
Market Cap: $248.897M info
ACH
Jun 15, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.03
Real-time Price: $3.19 info
Change: +$0.160 (+5%) info
Market Cap: $248.897M info
ACH
May 22, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.83
Real-time Price: $3.19 info
Change: +$0.360 (+13%) info
Market Cap: $248.897M info
ACH
May 11, 2026, 11:59 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.96
Real-time Price: $3.19 info
Change: -$0.770 (-19%) info
Market Cap: $248.897M info
ACH
May 11, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.84
Real-time Price: $3.19 info
Change: -$0.650 (-17%) info
Market Cap: $248.897M info
ACH
May 11, 2026, 6:35 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.58
Real-time Price: $3.19 info
Change: -$0.390 (-11%) info
Market Cap: $248.897M info
ACH
May 11, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $3.58
Real-time Price: $3.19 info
Change: -$0.390 (-11%) info
Market Cap: $248.897M info
ACH
May 04, 2026, 8:34 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.74
Real-time Price: $3.19 info
Change: -$0.550 (-15%) info
Market Cap: $248.897M info
ACH
Apr 02, 2026, 6:25 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $2.35
Real-time Price: $3.19 info
Change: +$0.840 (+36%) info
Market Cap: $248.897M info
ACH
Feb 20, 2026, 4:19 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $2.61
Real-time Price: $3.19 info
Change: +$0.580 (+22%) info
Market Cap: $248.897M info
ACH
Feb 19, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.40
Real-time Price: $3.19 info
Change: +$0.790 (+33%) info
Market Cap: $248.897M info